Polyneuropatier
Granskad av Dr Colin Tidy, MRCGPSenast uppdaterad av Dr Hayley Willacy, FRCGP Senast uppdaterad 21 okt 2024
Uppfyller patientens redaktionella riktlinjer
- Ladda nerLadda ner
- Dela
- Language
- Diskussion
- Ask Patient
- Ljudversion
- Lägg till i föredragna källor på Google
Medicinska yrkesverksamma
Professionella referensartiklar är utformade för att användas av hälso- och sjukvårdspersonal. De är skrivna av brittiska läkare och baserade på forskningsbevis, brittiska och europeiska riktlinjer. Du kanske hittar en av våra hälsoartiklar mer användbar.
See also the separate articles on Neurologisk historia och undersökning, Neurologisk undersökning av de nedre extremiteterna och Neurologisk undersökning av de övre extremiteterna.
What are polyneuropathies?
Polyneuropathies are the most common type of disorder of the peripheral nervous system in adults, especially the elderly, with an estimated prevalence of 5-8%, depending on age.1
Most polyneuropathies are chronic and usually develop over several months. Three main patterns of polyneuropathy can be distinguished and each has a different differential diagnosis:
Acute symmetrical peripheral neuropathy.
Chronic symmetrical peripheral neuropathy.
Multiple mononeuropathy.
Both peripheral and cranial nerves are affected, either by axonal degeneration (nerve becomes electrically inert within one week) or demyelination, which initially leaves the axon intact and results in blockage or slowing of conduction.
Symptoms of polyneuropathies (presentation)
Patients with polyneuropathy may present with altered sensation, pain, weakness or autonomic symptoms. Acute symmetrical polyneuropathy (eg, Guillain-Barrés syndrom) is uncommon.
Sensory polyneuropathy2
In sensory polyneuropathy, usually, the feet are affected first.
Paraesthesiae, numbness, burning pain, and loss of vibration sense and position sense are prominent. Muscle wasting may occur.
The sensory neuropathy may be subacute with ataxia caused by loss of sense of posture.
Autonom neuropati3
Polyneuropathy often affects the autonomic nervous system.
Typical symptoms are constipation, loss of bowel or bladder control and orthostatic hypotension. The skin may become pale and dry and sweating may be reduced.
Hereditary polyneuropathy4
Hereditary causes of polyneuropathy may also cause hammer toes, high arches and scoliosis.
Differentialdiagnos
Predominantly motor peripheral neuropathies include Guillain-Barrés syndrom, Charcot-Marie-Tooth syndrome, porfyri, lead poisoning och diphtheria.
Possible causes of painful peripheral neuropathy include alcoholic neuropathy, diabetic amyotrophy, porphyria, vitamin B1 deficiency or vitamin B12-brist and carcinoma.
The cause of chronic polyneuropathy is often unknown. The most common causes of peripheral neuropathy are:
Nutritional, including alcohol (with or without vitamin B1 deficiency), B12 deficiency.
Others causes include:
Tungmetallförgiftning - eg, lead, mercury.
Infection - eg, HIV, leprosy, diphtheria, tetanus, botulism.5
Malignancy - eg, lung cancer, breast cancer, myeloma.
Metabolic - eg, hypotyreos, liver failure, kronisk njursjukdom, acute intermittent porphyria.
Chronic vascular disease - eg, polyarteritis nodosa, systemisk lupus erythematosus.6
Chronic inflammatory demyelinative polyneuropathy.
Postinfective polyneuritis - eg, Guillain-Barré syndrome.
Drugs - eg, isoniazid, vincristine, phenytoin, nitrofurantoin, gold and excess amounts of vitamin B6 (pyridoxine).
Congenital - eg, Charcot-Marie-Tooth syndrome, Friedreich's ataxia, Refsums sjukdom, Anderson-Fabry sjukdom.
Diagnosing polyneuropathies (investigations)7
Initial tests include:
Urine: glucose, protein.
Haematology: FBC, erythrocyte sedimentation rate (ESR), vitamin B12, folate.
Biochemistry: fasting glucose, renal function, liver function and thyroid function.
Further investigations will depend on the outcome of clinical assessment and initial investigation results:
Neurophysiology testing with assessment of distal and proximal nerve stimulation; electrophysiological procedures are helpful in determining the pathological process which may be either an axonopathy, a myelinopathy or a neuronopathy.8
Biochemistry: serum protein electrophoresis, serum angiotensin-converting enzyme.
Immunology: antinuclear factor, anti-extractable nuclear antigen antibodies (anti-Ro, anti-La), antineutrophil cytoplasmic antigen antibodies.
Urine: Bence-Jones protein.
Cerebrospinal fluid: cells, protein, immunoglobulin oligoclonal bands.
Immunology: anti-HIV antibodies, antineuronal antibodies (Hu, Yo), antigliadin antibodies, serum angiotensin-converting enzyme, antiganglioside antibodies, antimyelin-associated glycoprotein antibodies.
Search for carcinoma, lymphoma or solitary myeloma.
Molecular genetic tests - eg, for Charcot-Marie-Tooth syndrome.
Nerve biopsy may be required.
Management of polyneuropathies
The initial assessment of the diagnosis and underlying cause is usually performed in secondary care. Re-referral may be indicated at a later stage if there is a significant deterioration in symptoms or an alteration in the presentation suggesting a further assessment is required.
Acute multiple mononeuropathy requires urgent assessment, as the most common cause is vasculitis. Prompt treatment with steroids, with or without cyclophosphamide, may prevent further irreversible nerve damage.
Preventative and palliative treatments include foot care, weight reduction, sensible footwear and foot orthoses.
Patients with severe leg weakness may need walking aids.
Simple wrist splints can help weak wrist extension.
Disabled patients require help from a multidisciplinary team including an occupational therapist and a physiotherapist.
Farmakologisk
Specific treatment depends on the cause.
Good control of glucose and blood pressure in patients with diabetes may improve or at least slow the progress of neuropathy.
Chronic inflammatory demyelinative polyneuropathy is treatable with corticosteroids, intravenous immunoglobulin, plasma exchange and some immunosuppressant drugs.9
Multifocal motor neuropathy responds to intravenous immunoglobulin, and possibly immunosuppressant drugs.10
No specific treatment is available for chronic idiopathic axonal polyneuropathy.
Painful neuropathy is difficult to treat. The most useful drugs are amitriptyline, duloxetine, gabapentin or pregabalin.11
Complications of polyneuropathies
With loss of sensation, recurrent injury to joints may lead to permanent joint destruction (Charcot joint).12
May lead to disability, social isolation or loss of independence, especially in the elderly.
Exklusiva uppdateringar för vårdpersonal
Håll dig informerad med de senaste kliniska uppdateringarna, professionella insikter och evidensbaserad vägledning. Patient Pro-nyhetsbrevet sammanställer viktigt innehåll för vårdpersonal—levererat direkt till din inkorg.
Genom att prenumerera accepterar du våra Sekretesspolicy. Du kan avsluta prenumerationen när som helst. Vi säljer aldrig dina uppgifter.
Vidare läsning och referenser
- Sommer C, Geber C, Young P, et al; Polyneuropathies. Dtsch Arztebl Int. 2018 Feb 9;115(6):83-90. doi: 10.3238/arztebl.2018.083.
- Freeman R, Gewandter JS, Faber CG, et al; Idiopathic distal sensory polyneuropathy: ACTTION diagnostic criteria. Neurology. 2020 Dec 1;95(22):1005-1014. doi: 10.1212/WNL.0000000000010988. Epub 2020 Oct 14.
- Vinik AI, Erbas T; Diabetic autonomic neuropathy. Handb Clin Neurol. 2013;117:279-94. doi: 10.1016/B978-0-444-53491-0.00022-5.
- Kramarz C, Rossor AM; Neurological update: hereditary neuropathies. J Neurol. 2022 Sep;269(9):5187-5191. doi: 10.1007/s00415-022-11164-1. Epub 2022 May 21.
- Brizzi KT, Lyons JL; Peripheral nervous system manifestations of infectious diseases. Neurohospitalist. 2014 Oct;4(4):230-40. doi: 10.1177/1941874414535215.
- Cojocaru IM, Cojocaru M, Silosi I, et al; Peripheral nervous system manifestations in systemic autoimmune diseases. Maedica (Buchar). 2014 Sep;9(3):289-94.
- Mirian A, Aljohani Z, Grushka D, et al; Diagnosis and management of patients with polyneuropathy. CMAJ. 2023 Feb 13;195(6):E227-E233. doi: 10.1503/cmaj.220936.
- Gwathmey KG, Pearson KT; Diagnosis and management of sensory polyneuropathy. BMJ. 2019 May 8;365:l1108. doi: 10.1136/bmj.l1108.
- Said G, Krarup C; Chronic inflammatory demyelinative polyneuropathy. Handb Clin Neurol. 2013;115:403-13. doi: 10.1016/B978-0-444-52902-2.00022-9.
- Muley SA, Parry GJ; Multifocal motor neuropathy. J Clin Neurosci. 2012 Sep;19(9):1201-9. doi: 10.1016/j.jocn.2012.02.011. Epub 2012 Jun 27.
- Neuropatisk smärta – farmakologisk behandling: Den farmakologiska behandlingen av neuropatisk smärta hos vuxna i icke-specialistmiljöer; NICE Klinisk Riktlinje (November 2013, senaste uppdatering September 2020)
- Galanis N, Kyriakou A, Delniotis I, et al; Charcot arthropathy: The diagnostic dilemma of a painless, destructive joint. Clin Case Rep. 2019 Dec 11;8(1):224-225. doi: 10.1002/ccr3.2603. eCollection 2020 Jan.
Om recensentenVisa fullständig biografi

Dr Colin Tidy, MRCGP
Allmänläkare, Medicinsk Författare
MBBS, MRCGP, MRCP (Paediatrics), DCH
Dr Colin Tidy är en NHS-läkare, baserad i Oxfordshire.
Artikelhistorik
Artikeln finns också på Engelska, Tyska, Spanska, Franska, Italienska, Portugisiska, Hindi, Hebreiska, Arabiska, och Svenska.
Nästa granskning: 20 okt 2027
21 okt 2024 | Senaste versionen
Mer inom neurologi
- Onormal gång
- Blefarospasm
- Kubitaltunnelsyndrom
- Undersökning av kranialnerverna
- Guillain-Barrés syndrom
- Huvudvärk från överanvändning av medicin
- Intrakraniell venös trombos
- Lambert-Eaton myasteniskt syndrom
- Landau-Kleffner syndrom
- Spetälska
- Meralgia paresthetica
- Mini mentalt tillståndsundersökning
- Paragonimiasis
- Paraproteinemi
- Pelizaeus-Merzbacher sjukdom
- Porphyrias
- Postherpetisk neuralgi
- Progressiv supranukleär pares
- Screening för kognitiv nedsättning
- Temporallobsskador


